Foreign Media: Renowned cancer scientist Feng Gensheng returned to China this month after conducting research in the United States for 40 years.

He once served as a distinguished professor at the University of California, San Diego, and now joins the Shenzhen Bay Laboratory as the director of the Cancer Research Institute. The Shenzhen Bay Laboratory is a research platform established by Guangdong Province and Shenzhen City to build an innovation and technology center.

Feng Gensheng's research focuses on the mechanisms of liver cancer recurrence and liver cancer immunotherapy. He discovered the SHP2 enzyme, which can affect protein stability and regulate the activity of other enzymes, helping to understand the mechanisms of cell regeneration and differentiation.

Original: www.toutiao.com/article/1840319652849863/

Statement: This article represents the views of the author.